G Mancia, G De Backer, A Dominiczak, R … - Journal of hypertension, 2007 - journals.lww.com Journal of Hypertension. Wolters Kluwer Health Logo. All Issues. ... Cited by 77 - Related articles - All 8 versions
- ►asnjournals.org DM Kent, TH Jafar, RA Hayward, H … - Journal of the American Society of Nephrology, 2007 - Am Soc Nephrol It is unclear whether patients with nondiabetic kidney disease benefit from
angiotensin-converting enzyme inhibitor (ACEI) therapy when they are at low risk
for disease progression or when they have low urinary protein excretion. ... Cited by 27 - Related articles - BL Direct - All 6 versions
- ►oxfordjournals.org HL Heerspink, T Greene, JB Lewis, I Raz, RD … - Nephrology Dialysis Transplantation, 2008 - ERA-EDTA Methods. A total of 149 patients with type 2 diabetes and an albumin:creatinine
ratio (ACR) between 20 and 300 mg/g were randomized with equal allocation to
either placebo, 200 mg of sulodexide or 400 mg of sulodexide. The primary ... Cited by 11 - Related articles - BL Direct - All 4 versions
- ►oxfordjournals.org LC Rump - Nephrology Dialysis Transplantation, 2007 - ERA-EDTA Inhibition of the renin–angiotensin system is the recommended standard
therapeutic regimen in chronic kidney disease. The reasons for this choice are
obvious. On the one hand angiotensin-converting enzyme (ACE) inhibitors and ... Cited by 11 - Related articles - BL Direct - All 3 versions
Y Yano, S Hoshide, J Ishikawa, C Noguchi, D … - American Journal of Hypertension, 2007 - Elsevier There were no significant changes in blood pressure (BP), glucose, and lipid
parameters between baseline and 12 weeks after randomization in either group.
There was a significant increase in high molecular weight adiponectin in ... Cited by 11 - Related articles - All 6 versions
- ►ahajournals.org P Farbom, B Wahlstrand, P Almgren, S Skrtic, … - Hypertension, 2008 - Am Heart Assoc We investigated whether renal function and microalbuminuria are independent
predictors and whether any interaction exists between them, regarding future
cardiovascular disease in hypertensive patients (n=10 881) followed for 4.5 ... Cited by 8 - Related articles - All 7 versions
GL Bakris, L Ruilope, F Locatelli, A … - Journal of human hypertension, 2006 - nature.com Declining kidney function predicts increasing cardiovascular risk in people with
hypertension. Microalbuminuria is a marker for cardiovascular risk and declining
kidney function. Agents that block the renin–angiotensin–aldosterone ... Cited by 8 - Related articles - BL Direct - All 4 versions
FW Asselbergs, WH van Gilst - Current Opinion in Cardiology, 2007 - journals.lww.com Purpose of review: Evidence from clinical trials suggests that angiotensin
converting enzyme (ACE) inhibition has the broadest impact of any class of drugs
in cardiovascular medicine, reducing cardiovascular morbidity and ... Cited by 7 - Related articles - BL Direct - All 5 versions
J Xu, WC Knowler, RB Devereux, J Yeh, JG … - American Journal of Kidney Diseases, 2007 - Elsevier During follow-up (average, 10.4 years), 383 incident nonfatal CVD and 145 fatal
CVD cases were ascertained. After adjustment for conventional CVD risk factors,
participants with a UACR in the third (UACR ≥ 5.4 to <10.2 mg/g [≥0.6 ... Cited by 8 - Related articles - All 19 versions
S Oparil, N Abate, E Chen, MA Creager, V … - Current Medical Research and Opinion®, 2008 - informahealthcare.com Objectives: The objective of this study was to evaluate the effects of losartan
± hydrochlorothiazide (HCTZ) versus placebo in obese patients with systolic and
diastolic hypertension. Research design and methods: Randomized patients (n ... Cited by 6 - Related articles - All 6 versions
